Lipedema

disease
On this page

Also known as Lipedema (disease)

Summary

Lipedema (MONDO:0013577) is a disease and 59 clinical trials. Top therapeutic interventions include ozone and utenpanium chloride. A subtype of subcutaneous tissue disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • ClinVar variants: 1
  • Clinical trials: 59

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical nameLipedema
Mondo IDMONDO:0013577
MeSHD065134
OMIM614103
Orphanet77243
SNOMED CT234102003
UMLSC0398370
MedGen451048
MedDRA10063955
Is cancer (heuristic)no

Also known as: lipedema · Lipedema (disease)

Data availability: 1 ClinVar variant · 1 HPO phenotype.

Disease family

This is a subtype of subcutaneous tissue disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › integumentary system disorder › subcutaneous tissue disorderLipedema

Related subtypes (18): nodular fasciitis, hemangioma of subcutaneous tissue, adiposis dolorosa, isolated anhidrosis with normal sweat glands, fibrodysplasia ossificans progressiva, multiple symmetric lipomatosis, familial multiple lipomatosis, familial angiolipomatosis, cerebrotendinous xanthomatosis, dissecting cellulitis of the scalp, Pierpont syndrome, CLOVES syndrome, encephalocraniocutaneous lipomatosis, FLOTCH syndrome, mycetoma, nodular non-suppurative panniculitis, Roch-Leri mesosomatous lipomatosis, cytophagic histiocytic panniculitis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

ClinVar germline variants

1 retrieved; paginated sample, class counts are floors:

1 pathogenic

ClinVarVariant (HGVS)GeneClassificationReview
26792346;XX;t(10;15)(q25.2;q11.2)Pathogeniccriteria provided, single submitter

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 59.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified58
PHASE21

Top trials by phase / activity

NCTPhaseStatusTitle
NCT03492840PHASE2COMPLETEDTreatment of Women With Lipedema Involving Substantial Fat Knee of Women and Men With Nodular Dercum’s Disease
NCT00833599Not specifiedENROLLING_BY_INVITATIONImaging Lymphatic Function in Normal Subjects and in Persons With Lymphatic Disorders
NCT04272827Not specifiedACTIVE_NOT_RECRUITINGEvaluation Between Surgical Therapy of Lipedema Compared to Complex Physical Decongestive Therapy (CDT) Alone
NCT04632810Not specifiedACTIVE_NOT_RECRUITINGEffect of Ketosis on Pain and Quality of Life in Patients With Lipedema
NCT05284266Not specifiedACTIVE_NOT_RECRUITINGThe National Lipedema Study
NCT05464927Not specifiedACTIVE_NOT_RECRUITINGVisualizing Vascular Mechanisms of Lipedema
NCT05628948Not specifiedRECRUITINGVascular Lab Resource (VLR) Biorepository
NCT05739279Not specifiedRECRUITINGSarcopenia and Related Factors in Lipedema
NCT06180850Not specifiedACTIVE_NOT_RECRUITINGBuilding Lipedema Research Resources
NCT06399367Not specifiedENROLLING_BY_INVITATIONInvestigation of Lipedema, Lymphedema and Vascular Malformations by Multispectral Optoacoustic Tomography (MSOT)
NCT06558851Not specifiedACTIVE_NOT_RECRUITINGThe Effect of Systematic Endurance Training in Treatment of Women With Lipedema
NCT06695403Not specifiedACTIVE_NOT_RECRUITINGTelerehabilitation Versus Supervised Pilates Training in Lipedema Women
NCT06770634Not specifiedRECRUITINGInvestigation of Central Sensitization and Associated Factors in Patients With Lipedema
NCT06811961Not specifiedRECRUITINGEffects of Exercise in Patients with Lipedema
NCT06964828Not specifiedRECRUITINGProof of Concept, Randomized, and Crossover Study, to Assess the Effectiveness of Two Types of Compression Garments in Lipedema
NCT07240415Not specifiedNOT_YET_RECRUITINGESWT for Primary Lipedema
NCT07294014Not specifiedRECRUITINGInvestigation of Medial Longitudinal Arch and Foot Function in Patients With Lipedema
NCT07319611Not specifiedNOT_YET_RECRUITINGInvestigation of the Effects of High-Intensity Interval Exercise and Moderate-Intensity Continuous Exercise on Limb Volume, Functional Capacity, and Quality of Life in Patients With Lipedema
NCT07404059Not specifiedAVAILABLEEffect of Ultrasound Cavitation Versus Pneumatic Compression on Adipose Tissue Thickness on Lipedema Patients
NCT07468097Not specifiedRECRUITINGThe Impact of Metabolic Status on Pain and Central Sensitization in Women With Lipedema: A Cross-Sectional Observational Study
NCT07489248Not specifiedRECRUITINGMultimodal Ultrasound for Differentiating Lymphedema and Lipedema
NCT07575555Not specifiedNOT_YET_RECRUITINGThe Effect of Lipedema on Knee Osteoarthritis
NCT07603076Not specifiedNOT_YET_RECRUITINGAssessment of Venous Insufficiency and Clinical Features in Lipedema
NCT02838277Not specifiedUNKNOWNInsight Into Subcutaneous Adipose Tissue Disorders
NCT02907411Not specifiedCOMPLETEDQuadrivas Therapy® to Reduce Lipedema Subcutaneous Adipose Tissue (QUADRIVAS)
NCT03271034Not specifiedCOMPLETEDEffect of Weight Loss on Body Composition and Metabolic Function in Women With Lipedema
NCT03634462Not specifiedCOMPLETEDComplete Decongestive Therapy With Negative Pressure for Lipedema and Lymphedema Therapy
NCT03710798Not specifiedCOMPLETEDEffect of an Low Carbon High Fat Diet on Pain- and Quality of Life in Patients With Lipedema
NCT03758651Not specifiedCOMPLETEDWilliams Syndrome Strength, Hormones, Activity & Adiposity, DNA Programming, Eating Study
NCT03853083Not specifiedUNKNOWNHYPOXI for Women With Lipedema
NCT03924999Not specifiedCOMPLETEDComparison of Complete Decongestive Therapy With Intermittent Pneumatic Compression for Treatment of Lipedema
NCT04166084Not specifiedUNKNOWNTrunk Stabilization Exercises at Lipoedema Patients
NCT04213989Not specifiedCOMPLETEDIntermittent Pneumatic Compression in Women With Lipo-lymphedema (Lipedema With Swelling)
NCT04492046Not specifiedCOMPLETEDComplex Decongestive Applications in Patients With Lipedema
NCT04643392Not specifiedCOMPLETEDPhysiotherapy Applications in Upper Extremity Lipedema
NCT05114317Not specifiedUNKNOWNCharacteristics of Pain in Women With Lipoedema
NCT05329324Not specifiedCOMPLETEDIs The Pain in Lipedema Patients Neuropathic Pain?
NCT05394467Not specifiedCOMPLETEDAdipose Cellular Kinetics of Lipedema
NCT05488977Not specifiedCOMPLETEDThe Effects of Endurance Training on Lipedema
NCT05616962Not specifiedCOMPLETEDVasculera in Participants With Lipedema

Drugs tested across these trials (top 30)

MoleculeMax phaseTrials referencing
OZONE31
UTENPANIUM CHLORIDE21